Peptron, Inc. (KOSDAQ:087010)
South Korea
· Delayed Price · Currency is KRW 268,000
-2,500 (-0.92%)
Apr 29, 2026, 2:10 PM KST
Peptron Revenue
In the year 2025, Peptron had annual revenue of 5.63B KRW with 78.76% growth. Peptron had revenue of 987.28M in the quarter ending December 31, 2025, a decrease of -36.08%.
Revenue
5.63B
Revenue Growth
+78.76%
P/S Ratio
1,119.35
Revenue / Employee
n/a
Employees
n/a
Market Cap
6,307.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.63B | 2.48B | 78.76% |
| Dec 31, 2024 | 3.15B | -189.71M | -5.68% |
| Dec 31, 2023 | 3.34B | -2.47B | -42.52% |
| Dec 31, 2022 | 5.81B | -810.52M | -12.24% |
| Dec 31, 2021 | 6.62B | 3.50B | 112.28% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| LigaChem Biosciences | 141.55B |
| Voronoi | 7.51B |
| SK Biopharmaceuticals | 706.74B |
| HLB Co., Ltd. | 84.17B |
| OliX Pharmaceuticals | 14.67B |
| D&D Pharmatech | 4.30B |
| PharmaResearch | 536.29B |
| SK bioscience | 651.37B |